Announced Thu, 9 Jul · 16:01 IST
Board Meeting on 20 July 2026 to Consider Q1 FY27 Results
Results View source PDF
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+5.0%1-day move
₹1720.00
prior close
₹1739.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.6—-0.7+0.0+5.0+10.2+6.6+4.7+2.6+3.4————
Up moveDown movePending
AI summary
Venus Remedies has informed BSE that its Board of Directors will meet on 20 July 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30 June 2026. The trading window for designated persons has been closed from 1 July 2026 until 48 hours after the results are declared.
Likely market impact
Investors await Q1 FY27 results and any other announcements from the board on 20 July 2026. No business decision implied yet.